ANDROGEN RESPONSIVENESS OF THE NEW HUMAN ENDOMETRIAL CANCER CELL-LINE MFE-296

被引:38
作者
HACKENBERG, R
BECK, S
FILMER, A
NIA, AH
KUNZMANN, R
KOCH, M
SLATER, EP
SCHULZ, KD
机构
[1] UNIV FREIBURG,MED KLIN,D-79106 FREIBURG,GERMANY
[2] UNIV MARBURG,MED ZENTRUM HUMANGENET,D-35033 MARBURG,GERMANY
[3] UNIV MARBURG,INST MOLEK BIOL & TUMORFORSCH,D-35033 MARBURG,GERMANY
关键词
D O I
10.1002/ijc.2910570121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MFE-296 endometrial cancer cells express androgen receptors in vitro. These cells, which are tumorigenic in nude mice, are derived from a moderately differentiated human endometrial adenocarcinoma. They express vimentin and the cytokeratins 7, 8, 18, and 19. Karyotyping revealed near-tetraploidy for most of the cells. No marker chromosomes were observed. DNA analyses confirmed the genetic identity of the cell line and the patient from whom the cell line was derived. Proliferation of MFE-296 cells was inhibited by the progestin R5020 and the androgen dihydrotestosterone (DHT). The inhibition of proliferation by DHT was antagonized by the antiandrogen Casodex, demonstrating the involvement of the androgen receptor. Androgen binding was determined at 22,000 binding sites per cell using a whole-cell assay (K-D = 0.05 nM) and 30 fmol/mg protein with the dextran charcoal method; 7 fmol/mg protein of progesterone receptors were found, whereas estrogen receptors were below 5 fmol/mg protein. The androgen receptor was functionally intact, as demonstrated by transfection experiments with a reporter-gene construct, containing an androgen-responsive element. In MFE-296 cells the content of the androgen receptor was up-regulated by its own ligand. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 29 条
[1]  
CENTOLA GM, 1985, CANCER RES, V45, P6264
[2]   INFLUENCE OF CYTOPLASMIC STEROID-RECEPTOR CONTENT ON PROGNOSIS OF EARLY STAGE ENDOMETRIAL CARCINOMA [J].
CREASMAN, WT ;
SOPER, JT ;
MCCARTY, KS ;
MCCARTY, KS ;
HINSHAW, W ;
CLARKEPEARSON, DL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 151 (07) :922-932
[3]  
GIANNAKUDIS J, 1987, CYTOGENET CELL GENET, V46, P619
[4]  
GOLDENBERG IS, 1964, JAMA-J AM MED ASSOC, V188, P1069
[5]  
GONG YW, 1991, CANCER RES, V51, P5476
[6]   ESTABLISHMENT AND CHARACTERIZATION OF A NEW ENDOMETRIAL CANCER CELL-LINE (SCRC-1) [J].
GORODECKI, J ;
MORTEL, R ;
LADDA, RL ;
WARD, SP ;
GEDER, L ;
RAPP, F .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 135 (05) :671-679
[7]   ENDOMETRIAL CANCER - BIOCHEMICAL AND CLINICAL CORRELATES [J].
GURPIDE, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (06) :405-416
[8]   MEDROXYPROGESTERONE ACETATE INHIBITS THE PROLIFERATION OF ESTROGEN-RECEPTOR AND PROGESTERONE-RECEPTOR NEGATIVE MFM-223 HUMAN MAMMARY-CANCER CELLS VIA THE ANDROGEN RECEPTOR [J].
HACKENBERG, R ;
HAWIGHORST, T ;
FILMER, A ;
NIA, AH ;
SCHULZ, KD .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 25 (03) :217-224
[9]  
HACKENBERG R, 1991, CANCER RES, V51, P5722
[10]   REGULATION OF ANDROGEN RECEPTOR MESSENGER-RNA AND PROTEIN LEVEL BY STEROID-HORMONES IN HUMAN MAMMARY-CANCER CELLS [J].
HACKENBERG, R ;
HAWIGHORST, T ;
FILMER, A ;
SLATER, EP ;
BOCK, K ;
BEATO, M ;
SCHULZ, KD .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (07) :599-607